Literature DB >> 28571613

Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy.

Prodromos Parasoglou1, Smita Rao2, Jill M Slade3.   

Abstract

PURPOSE: The present review highlights current concepts regarding the effects of diabetic peripheral neuropathy (DPN) in skeletal muscle. It discusses the lack of effective pharmacologic treatments and the role of physical exercise intervention in limb protection and symptom reversal. It also highlights the importance of magnetic resonance imaging (MRI) techniques in providing a mechanistic understanding of the disease and helping develop targeted treatments.
METHODS: This review provides a comprehensive reporting on the effects of DPN in the skeletal muscle of patients with diabetes. It also provides an update on the most recent trials of exercise intervention targeting DPN pathology. Lastly, we report on emerging MRI techniques that have shown promise in providing a mechanistic understanding of DPN and can help improve the design and implementation of clinical trials in the future.
FINDINGS: Impairments in lower limb muscles reduce functional capacity and contribute to altered gait, increased fall risk, and impaired balance in patients with DPN. This finding is an important concern for patients with DPN because their falls are likely to be injurious and lead to bone fractures, poorly healing wounds, and chronic infections that may require amputation. Preliminary studies have shown that moderate-intensity exercise programs are well tolerated by patients with DPN. They can improve their cardiorespiratory function and partially reverse some of the symptoms of DPN. MRI has the potential to bring new mechanistic insights into the effects of DPN as well as to objectively measure small changes in DPN pathology as a result of intervention. IMPLICATIONS: Noninvasive exercise intervention is particularly valuable in DPN because of its safety, low cost, and potential to augment pharmacologic interventions. As we gain a better mechanistic understanding of the disease, more targeted and effective interventions can be designed.
Copyright © 2017 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Keywords:  MRI; diabetic peripheral neuropathy; exercise therapy; skeletal muscle

Mesh:

Year:  2017        PMID: 28571613      PMCID: PMC5503477          DOI: 10.1016/j.clinthera.2017.05.001

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  167 in total

1.  Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue.

Authors:  Dympna Gallagher; Patrick Kuznia; Stanley Heshka; Jeanine Albu; Steven B Heymsfield; Bret Goodpaster; Marjolein Visser; Tamara B Harris
Journal:  Am J Clin Nutr       Date:  2005-04       Impact factor: 7.045

2.  Risk factors for amputation in patients with diabetes mellitus. A case-control study.

Authors:  G E Reiber; R E Pecoraro; T D Koepsell
Journal:  Ann Intern Med       Date:  1992-07-15       Impact factor: 25.391

Review 3.  Intramyocellular lipids and insulin resistance.

Authors:  Jürgen Machann; Hans Häring; Fritz Schick; Michael Stumvoll
Journal:  Diabetes Obes Metab       Date:  2004-07       Impact factor: 6.577

4.  Effects of Tai Chi Exercise on glucose control, neuropathy scores, balance, and quality of life in patients with type 2 diabetes and neuropathy.

Authors:  Sukhee Ahn; Rhayun Song
Journal:  J Altern Complement Med       Date:  2012-09-17       Impact factor: 2.579

Review 5.  The burden of diabetic foot ulcers.

Authors:  G E Reiber; B A Lipsky; G W Gibbons
Journal:  Am J Surg       Date:  1998-08       Impact factor: 2.565

6.  Length dependent loss of motor axons and altered motor unit properties in human diabetic polyneuropathy.

Authors:  Matti D Allen; Kurt Kimpinski; Timothy J Doherty; Charles L Rice
Journal:  Clin Neurophysiol       Date:  2013-10-26       Impact factor: 3.708

7.  Skeletal muscle dysfunction in the db/db mouse model of type 2 diabetes.

Authors:  Jeppe Seamus Bayley; Thomas Holm Pedersen; Ole Baekgaard Nielsen
Journal:  Muscle Nerve       Date:  2016-06-09       Impact factor: 3.217

8.  Diabetes-related complications, glycemic control, and falls in older adults.

Authors:  Ann V Schwartz; Eric Vittinghoff; Deborah E Sellmeyer; Kenneth R Feingold; Nathalie de Rekeneire; Elsa S Strotmeyer; Ronald I Shorr; Aaron I Vinik; Michelle C Odden; Seok Won Park; Kimberly A Faulkner; Tamara B Harris
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

9.  Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade.

Authors:  Stephan Morbach; Heike Furchert; Ute Gröblinghoff; Heribert Hoffmeier; Kerstin Kersten; Gerd-Thomas Klauke; Ulrike Klemp; Thomas Roden; Andrea Icks; Burkhard Haastert; Gerhard Rümenapf; Zulfiqarali G Abbas; Manish Bharara; David G Armstrong
Journal:  Diabetes Care       Date:  2012-07-18       Impact factor: 19.112

10.  Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.

Authors:  Dan Ziegler; Lusine Movsesyan; Boris Mankovsky; Irina Gurieva; Zhangentkhan Abylaiuly; Igor Strokov
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

View more
  13 in total

1.  Immediate Effect of Manual Therapy on Tibiotarsal Joint Mobility and Static Balance in Individuals With Diabetes.

Authors:  Catarina Clapis Zordão; Emilson Sodré Mendonça Junior; Paola Marini Valério; Carla Silva Perez; Ana Paula Ferro; Elaine Caldeira de Oliveira Guirro
Journal:  J Chiropr Med       Date:  2022-01-31

2.  Simultaneous T1 , T2 , and T relaxation mapping of the lower leg muscle with MR fingerprinting.

Authors:  Azadeh Sharafi; Katherine Medina; Marcelo W V Zibetti; Smita Rao; Martijn A Cloos; Ryan Brown; Ravinder R Regatte
Journal:  Magn Reson Med       Date:  2021-02-08       Impact factor: 3.737

3.  Multicomponent Exercise Improves Hemodynamic Parameters and Mobility, but Not Maximal Walking Speed, Transfer Capacity, and Executive Function of Older Type II Diabetic Patients.

Authors:  Hélio José Coelho Junior; Iris Callado Sanches; Marcio Doro; Ricardo Yukio Asano; Daniele Jardim Feriani; Cayque Brietzke; Ivan de Oliveira Gonçalves; Marco Carlos Uchida; Erico Chagas Capeturo; Bruno Rodrigues
Journal:  Biomed Res Int       Date:  2018-02-14       Impact factor: 3.411

4.  Impact of lower limb muscle strength on walking function beyond aging and diabetes.

Authors:  Ran Wu; Yan Zhang; Jiao-Jiao Bai; Jiao Sun; Zhi-Jun Bao; Zheng Wang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

5.  Comparison of the effect of two therapeutic exercises on the inflammatory and physiological conditions and complications of diabetic neuropathy in female patients.

Authors:  Maryam Nadi; Effat Bambaeichi; Seyyed Mohammad Marandi
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-20       Impact factor: 3.168

Review 6.  Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes.

Authors:  Alec T Beeve; Jennifer M Brazill; Erica L Scheller
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

7.  Foot function and strength of patients with diabetes grouped by ulcer risk classification (IWGDF).

Authors:  Jane S S P Ferreira; João P Panighel; Érica Q Silva; Renan L Monteiro; Ronaldo H Cruvinel Júnior; Isabel C N Sacco
Journal:  Diabetol Metab Syndr       Date:  2019-10-30       Impact factor: 3.320

8.  Not Only Diabetes but Also Prediabetes Leads to Functional Decline and Disability in Older Adults.

Authors:  Ying Shang; Laura Fratiglioni; Davide Liborio Vetrano; Abigail Dove; Anna-Karin Welmer; Weili Xu
Journal:  Diabetes Care       Date:  2021-01-14       Impact factor: 19.112

9.  Applicability of High-Frequency Ultrasound to the Early Diagnosis of Diabetic Peripheral Neuropathy.

Authors:  Xishun Ma; Tongxia Li; Lizhen Du; Gang Liu; Ting Sun; Tongliang Han
Journal:  Biomed Res Int       Date:  2021-03-18       Impact factor: 3.411

Review 10.  Quantification of Mitochondrial Oxidative Phosphorylation in Metabolic Disease: Application to Type 2 Diabetes.

Authors:  Matthew T Lewis; Jonathan D Kasper; Jason N Bazil; Jefferson C Frisbee; Robert W Wiseman
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.